We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTeplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.AuthorsHerold, K.; Gitelman, S.; Willi, S.; Gottlieb, P.; Waldron-Lynch, F.; Devine, L.; Sherr, J.; Rosenthal, S.; Adi, S.; Jalaludin, M.; Michels, A.; Dziura, J.; Bluestone, J.PublicationDiabetologia, 2013, Vol 56, Issue 2, p391ISSN0012-186xPublication typearticleDOI10.1007/s00125-012-2753-4